Clinical Trial Update: Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing drug-drug interactions and intensive pharmacokinetic/pharmacodynamic profiling of brodalumab in psoriasis patients; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2017-04-10